JAK inhibitor provides rapid, durable relief for patients of myelofibrosis -- life-threatening bone marrow malignancy
Tuesday, September 28, 2010 - 18:15
in Health & Medicine
An oral medication produces significant and lasting relief for patients with myelofibrosis, a debilitating and lethal bone marrow disorder, researchers report.